Much Ado Abbott Nothing
Abbott Laboratories(ABT) is joining the parade and splitting itself into two. Like many other recent spinners, Abbott is a spinoff veteran, having spun off Hospira(HSP) in 2004. Though at times, even...
View ArticleSorry Costello – Abbott Chooses AbbVie For Spinoff Name
After covering Kraft’s (poor) choice in naming its spinoff, we now move onto mocking examining Abbott’s (ABT) choice of the name AbbVie for its new pharmaceuticals company. Sadly, this now means that...
View ArticleRecord Debt Sale Preps AbbVie For January Spin From Abbott Laboratories
Earlier this month, AbbVie (ABBV) completed a debt offering totaling $14.7 billion, making it the largest high grade offering in U.S history by over $1 billion and the largest of the year by nearly $5...
View ArticleAbbott Board Approves AbbVie Spin
Abbott’s(ABT) spinoff of AbbVie(ABBV) passed its final hurdle yesterday as the Board approved the plan. Shareholders of Abbott at the close of business on December 12 will receive, on January 1, one...
View ArticleFinal Stretch For Abbott Spin As Effective Date Nears, AbbVie Begins When...
On Friday, Abbott(ABT) announced the effectiveness of the registration statement for its AbbVie(ABBV) spin. As we discussed previously, Abbott shareholders will get one AbbVie share for each Abbott...
View ArticleFor Whom The Dell Tolls- Newborn AbbVie To Replace Dell In S&P 100, To Join...
Some spinoffs are tiny, others are born big. AbbVie(ABBV) is a case of the latter. With a market cap of over $50 Billion, it begins life as a megacap when it spins off on January 2 from Abbott...
View ArticleAbbVie Spin From Abbott Complete Today – Discussion Thread
After long preparations, Humira manufacturer AbbVie(ABBV) has been spun off from former parent Abbott Laboratories(ABT). Abbott shareholders will wake up to find one share of AbbVie in their account...
View ArticleAbbott and AbbVie- Spinoff Complete, Companies Begin To Walk Their Own Paths
On Wednesday, Abbott Laboratories(ABT) completed its spinoff of AbbVie(ABBV), and the two firms began their new, independent lives. As is often the case, as their first acts, each company issued a...
View ArticleAbbVie Declares $.40 Dividend, Yield Stands At Over 4.6%
Not wasting any time, AbbVie(ABBV) declared a $.40 quarterly dividend on Friday, two days after its spin off from Abbott Laboratories(ABT). At Friday’s closing price of $34.39, the stock yields 4.65%....
View ArticleBad Data Leads To Bad Conclusion In Seeking Alpha AbbVie/Abbott Analysis
AbbVie(ABBV) is one of the most massive spinoffs we’ve seen, so every piece of news or analysis is of interest to us. Hence it was with great interest that we noted that Seeking Alpha published...
View ArticleAbbVie CFO: Big Acquisiton Not Prudent
AbbVie(ABBV) is a behemoth of a company following its spinoff from Abbott Laboratories(ABT), but it is a one-legged giant. The chorus of concern around the companies prospects has centered on its...
View ArticleCan’t Decide Which One To Own? Cramer Picks Abbott Over AbbVie
Amidst our exhaustive coverage of the Abbott (ABT)/AbbVie (ABBV) separation, there has been no consensus as to which company is the ‘better’ one to own. Some people like AbbVie’s higher dividend yield...
View Article13F Time: Bill Ackman Sells Alexander & Baldwin, Nelson Peltz Sells Kraft and...
13F season is always fun as it provides a rare (albeit delayed) glimpse into the thinking of large money managers and hedge funds. Of course, due to the significant time lag (~45 days), the exclusion...
View ArticleMuch Ado Abbott Nothing
Abbott Laboratories(ABT) is joining the parade and splitting itself into two. Like many other recent spinners, Abbott is a spinoff veteran, having spun off Hospira(HSP) in 2004. Though at times, even...
View ArticleSorry Costello – Abbott Chooses AbbVie For Spinoff Name
After covering Kraft’s (poor) choice in naming its spinoff, we now move onto mocking examining Abbott’s (ABT) choice of the name AbbVie for its new pharmaceuticals company. Sadly, this now means that...
View ArticleRecord Debt Sale Preps AbbVie For January Spin From Abbott Laboratories
Earlier this month, AbbVie (ABBV) completed a debt offering totaling $14.7 billion, making it the largest high grade offering in U.S history by over $1 billion and the largest of the year by nearly $5...
View ArticleAbbott Board Approves AbbVie Spin
Abbott’s(ABT) spinoff of AbbVie(ABBV) passed its final hurdle yesterday as the Board approved the plan. Shareholders of Abbott at the close of business on December 12 will receive, on January 1, one...
View ArticleFinal Stretch For Abbott Spin As Effective Date Nears, AbbVie Begins When...
On Friday, Abbott(ABT) announced the effectiveness of the registration statement for its AbbVie(ABBV) spin. As we discussed previously, Abbott shareholders will get one AbbVie share for each Abbott...
View ArticleFor Whom The Dell Tolls- Newborn AbbVie To Replace Dell In S&P 100, To Join...
Some spinoffs are tiny, others are born big. AbbVie(ABBV) is a case of the latter. With a market cap of over $50 Billion, it begins life as a megacap when it spins off on January 2 from Abbott...
View ArticleAbbVie Spin From Abbott Complete Today – Discussion Thread
After long preparations, Humira manufacturer AbbVie(ABBV) has been spun off from former parent Abbott Laboratories(ABT). Abbott shareholders will wake up to find one share of AbbVie in their account...
View Article
